Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis

(1) Background: To explore the impact of the degree of inflammation on voriconazole exposure in critically ill patients affected by COVID-associated pulmonary aspergillosis (CAPA); (2) Methods: Critically ill patients receiving TDM-guided voriconazole for the management of proven or probable CAPA be...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatti, Milo, Fornaro, Giacomo, Pasquini, Zeno, Zanoni, Andrea, Bartoletti, Michele, Viale, Pierluigi, Pea, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134964/
https://www.ncbi.nlm.nih.gov/pubmed/37107125
http://dx.doi.org/10.3390/antibiotics12040764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134964/
https://www.ncbi.nlm.nih.gov/pubmed/37107125
http://dx.doi.org/10.3390/antibiotics12040764

Ejemplares similares